Mismatched stem cell transplant
Showing 1 - 25 of >10,000
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- BPX-501 dose 1
- +5 more
-
Atlanta, Georgia
- +7 more
Jul 10, 2022
Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)
Recruiting
- Hematologic Malignancy
- Stem Cell Transplant Complications
- Beijing protocol
-
Beijing, Beijing, ChinaDeparment of Hematology, Peking University People's Hospital
Jun 19, 2023
End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,
Not yet recruiting
- End Stage Kidney Disease
- +3 more
- Donor CD34+, CD3+. and belumosudil
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Apr 6, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Sickle Cell Disease Trial in Saint Louis (drug, radiation, procedure)
Terminated
- Sickle Cell Disease
- Alemtuzumab
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 28, 2022
Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)
Recruiting
- Hematologic Malignancies
- Fludarabine
- +7 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022
Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,
Completed
- Chronic Myelogenous Leukemia
- +9 more
- Fludarabine
- +3 more
-
Atlanta, GeorgiaNorthside Hospital
Apr 4, 2022
Acute Leukemia, MDS Trial in Chicago (device, drug, other)
Recruiting
- Acute Leukemia
- MDS
- Arm1
- Arm 1
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Oct 13, 2022
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,
Completed
- Acute Myeloid Leukemia
- Advanced Myelodysplastic Syndromes
- Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Aug 27, 2021
Myeloid Malignancies Trial in Italy (GvHD prophylaxis)
Recruiting
- Myeloid Malignancies
- GvHD prophylaxis
-
Alessandria, Italy
- +32 more
Nov 23, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical
Recruiting
- Acute Myeloid Leukemia
- +10 more
- TCRαβ+/CD19+ depleted Haploidentical HSCT
- Zoledronate
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 1, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)
Not yet recruiting
- Acute Leukemia
- +6 more
- Cyclophosphamide
- +8 more
- (no location specified)
Dec 8, 2021
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)
Recruiting
- AML - Acute Myeloid Leukemia
- +5 more
- T-allo10
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Feb 2, 2022
Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)
Not yet recruiting
- Acute Leukemia
- Rifaximin with allogeneic stem cell transplant
- Allogeneic stem cell transplant
- (no location specified)
Sep 21, 2023
Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)
Recruiting
- Transplant-Related Hematologic Malignancy
- Sargramostim
- Control Arm
-
Atlanta, GeorgiaNorthside Hospital
Oct 19, 2022
Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)
Recruiting
- Haploidentical Hematopoietic Stem Cell Transplantation
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 11, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Stem Cell Trial in Houston (Enteral nutrition (EN), Standard care parenteral nutrition (PN))
Recruiting
- Stem Cell
- Enteral nutrition (EN)
- Standard care parenteral nutrition (PN)
-
Houston, TexasM D Anderson Cancer Center
Aug 23, 2023
Intestinal Microbiota in Stem Cell Transplant Transplant
Recruiting
- Stem Cell Transplant Complications
- intestinal microbiota
-
Detroit, MichiganHenry Ford Health System
Dec 27, 2022
Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)
Recruiting
- Sickle Cell Disease
- Bone Marrow Transplant (BMT)
- +7 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Sep 13, 2022